Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Easter...
February 13 2020 - 9:00AM
Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions
company with the first and only FDA-approved swallowable,
gas-filled intragastric balloon system for the treatment of
obesity, announces that it plans to release its fourth quarter
and year-end 2019 financial results before the market opens on
Thursday, February 27, 2020 and hold a conference call at 8:30 AM
Eastern Time (5:30 AM Pacific Time) to discuss the Company's
financial results and provide a business update. Interested parties
may access the conference call by dialing (844) 889-7791 (U.S.) or
(661) 378-9934 (international) using passcode 6573298. Media and
individuals will be in a listen-only mode. Participants are asked
to dial in a few minutes prior to the call to register for the
event. The conference call will also be webcast live at:
https://edge.media-server.com/mmc/p/c8zmkz5x.
An archive of the webcast will be available for twelve months
following the event on the Obalon Therapeutics website located at
http://investor.obalon.com in the “News & Events”
section.
About Obalon Therapeutics, Inc. Obalon
Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company
focused on developing and commercializing novel technologies for
weight loss. For more information, please
visit www.obalon.com.
For Obalon Therapeutics, Inc.
Investor Contact:William PlovanicPresident & Chief Executive
OfficerObalon Therapeutics, Inc.Office: +1 760 607
5103wplovanic@obalon.com
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Sep 2023 to Sep 2024